ATE342049T1 - Mikroverkapselte und mit gesteurter freigabe kräuter formulierungen - Google Patents

Mikroverkapselte und mit gesteurter freigabe kräuter formulierungen

Info

Publication number
ATE342049T1
ATE342049T1 AT00935455T AT00935455T ATE342049T1 AT E342049 T1 ATE342049 T1 AT E342049T1 AT 00935455 T AT00935455 T AT 00935455T AT 00935455 T AT00935455 T AT 00935455T AT E342049 T1 ATE342049 T1 AT E342049T1
Authority
AT
Austria
Prior art keywords
formulation
release
controlled
encapsuled
micro
Prior art date
Application number
AT00935455T
Other languages
English (en)
Inventor
Yoav Blatt
Eugene Kimmelman
David Cohen
Avner Rotman
Original Assignee
Bio Dar Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Dar Ltd filed Critical Bio Dar Ltd
Application granted granted Critical
Publication of ATE342049T1 publication Critical patent/ATE342049T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5036Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT00935455T 1999-06-07 2000-06-07 Mikroverkapselte und mit gesteurter freigabe kräuter formulierungen ATE342049T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/327,752 US6340478B1 (en) 1999-06-07 1999-06-07 Microencapsulated and controlled-release herbal formulations

Publications (1)

Publication Number Publication Date
ATE342049T1 true ATE342049T1 (de) 2006-11-15

Family

ID=23277898

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00935455T ATE342049T1 (de) 1999-06-07 2000-06-07 Mikroverkapselte und mit gesteurter freigabe kräuter formulierungen

Country Status (7)

Country Link
US (1) US6340478B1 (de)
EP (1) EP1278514B1 (de)
AT (1) ATE342049T1 (de)
AU (1) AU5099400A (de)
DE (1) DE60031307T2 (de)
ES (1) ES2273697T3 (de)
WO (1) WO2000074656A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL131508A (en) * 1999-08-19 2006-12-10 David Cohen Microencapsulated and controlled-release formulations of isoflavone from enriched fractions of soy and other plants
DE10012569A1 (de) * 2000-03-15 2001-09-20 Finzelberg Gmbh & Co Kg Hartgelatinekapseln enthaltend retardierte Pflanzenextrakte und Verfahren zur Herstellung derselben
DE10158281A1 (de) * 2001-11-19 2003-05-28 Mediwirk Gmbh Pharmazeutisches Präparat
US20040208928A1 (en) * 2003-04-15 2004-10-21 Animal Technology Institute Taiwan Method for preparing an orally administrable formulation for controlled release
BRPI0415242B8 (pt) * 2003-10-10 2021-05-25 Ethypharm Sa microgrânulos de liberação gradual contendo extrato de gingko biloba e o processo para fabricar estes
EP1602364A1 (de) * 2004-05-25 2005-12-07 Cognis IP Management GmbH Mikrokapseln (XXX), enthaltend Pflanzenextrakte, und Verfahren zu deren Herstellung
US20060115556A1 (en) * 2004-12-01 2006-06-01 Foulger Sidney W Nutritional supplement drink containing xanthone extracts
US20060115555A1 (en) * 2004-12-01 2006-06-01 Foulger Sidney W Nutritional supplements containing xanthone extracts
DK2060192T3 (en) * 2007-10-17 2016-02-22 Wild Gmbh & Co Kg Rudolf Composition comprising lemon balm extracts
JP2011506934A (ja) * 2007-12-06 2011-03-03 ペイン セラピューティクス インコーポレイテッド 溶解試験装置および試験のための方法
FR2952824B1 (fr) * 2009-11-23 2011-11-11 Aliou Mamadou Balde Composition antidiabetique contenant un extrait vegetal d'englerina lecardii
CH704253A1 (de) * 2010-12-21 2012-06-29 Mepha Gmbh Pharmazeutische Zusammensetzung enthaltend pflanzliche Wirkstoffe.
US11229600B2 (en) * 2014-09-24 2022-01-25 Vital Beverages Global Inc. Compositions and methods for selective GI tract delivery
GB201420311D0 (en) 2014-11-14 2014-12-31 Bio Images Drug Delivery Ltd Pharmaceutical processing
GB201420306D0 (en) 2014-11-14 2014-12-31 Bio Images Drug Delivery Ltd Compositions
GB201420300D0 (en) 2014-11-14 2014-12-31 Bio Images Drug Delivery Ltd Tablet
EP4702975A1 (de) * 2024-09-03 2026-03-04 Biotecnica Di Magagnini Mattia E Malatini Silvia Snc Stp Nahrungsergänzungsmittel zur behandlung von blasenentzündungen

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8500724A (nl) * 1985-03-13 1986-10-01 Univ Groningen Inrichtingen voor geregelde afgifte van werkzame stoffen, alsmede werkwijze ter vervaardiging daarvan.
FR2715582B1 (fr) 1994-02-02 1996-03-15 Centre Nat Rech Scient Microcapsules à paroi de flavonoïde réticulée et compositions en contenant.
DE4434170C1 (de) 1994-09-24 1996-03-28 Krewel Werke Gmbh Johanniskrautextrakte
US5560928A (en) * 1995-06-23 1996-10-01 Defelice; Stephen L. Nutritional and/or dietary composition and method of using the same
US5985282A (en) * 1997-01-22 1999-11-16 Hpf, L.L.C. Herbal appetite suppressant and weight loss composition
EP0922450B1 (de) * 1997-12-01 2003-04-23 Dr. Gergely & Co. Brausezubereitung enthaltend ein Pflanzenextrakt
US6270803B1 (en) * 1998-10-07 2001-08-07 Bio Dar Ltd. Controlled-release garlic formulations
AR020343A1 (es) * 1998-11-24 2002-05-08 Steigerwald Arzlneimittelwerk Metodo para producir farmacos que contienen extractos de plantas en una forma solida de aplicacion.

Also Published As

Publication number Publication date
DE60031307T2 (de) 2007-05-24
WO2000074656A1 (en) 2000-12-14
US6340478B1 (en) 2002-01-22
EP1278514A1 (de) 2003-01-29
ES2273697T3 (es) 2007-05-16
AU5099400A (en) 2000-12-28
DE60031307D1 (de) 2006-11-23
EP1278514B1 (de) 2006-10-11

Similar Documents

Publication Publication Date Title
ATE342049T1 (de) Mikroverkapselte und mit gesteurter freigabe kräuter formulierungen
WO2004043513A3 (en) Surface dissolution and/or bulk erosion controlled release compositions and devices
NO175240C (no) Fremgangsmåte for fremstilling av et langsomt frigivende farmasöytisk preparat som omfatter sekundære granuler
IL114641A (en) Pharmaceutical compositions containing dispersible fluoxetine
DK1073415T3 (da) Gelerbare farmaceutiske sammensætninger
HUT48821A (en) Process for production of medical compositions
DE69730991D1 (de) Alginsaure enthaltende enterischer ueberzug fuer eine orale zubereitung
NO307594B1 (no) Fremgangsmåte for fremstilling av en tørr, hydratisert cefalosporinpulverformulering, og farmsøytisk preparat
FR2726469B1 (fr) Composition pharmaceutique pour l'administration orale de flavonoides
NO20010957D0 (no) Nye hydratformer av alendronatnatrium, fremgangsmÕter for fremstilling av disse og farmasøytiske preparater derav
PL321567A1 (en) Oral administration forms containing a beta-lactame antibiotic
GB2359022A (en) Controlled-release garlic formulations
PL327323A1 (en) Orally administered 5-asa containing pharmaceutic composition of modified active substance release and method of treating intestinal diseases
GB9119052D0 (en) Pharmaceutical compositions
ATE271854T1 (de) Acetaminophen-formulierung mit verlängerter freisetzung
CA2339931A1 (en) Extended release acetaminophen
DK1009380T3 (da) Fremgangsmåde til fremstilling af farmaceutiske formuleringer
KR100349249B1 (ko) 단일 펠렛형 서방성 제제
YU20050411A (sh) Komopzicije oksikodona sa kontrolisanim oslobadanjem
JPS62238214A (ja) 浴用剤
HUP9902179A2 (hu) Hatóanyagként cisapridot tartalmazó PH-tól független, azonnali hatóanyag felszabadításra alkalmas szilárd gyógyszerkészítmény
BR9802588A (pt) Processo para preparação de composições granuladas contendo macrolìdeos de eritromicina e processo para preparação de composições farmaceuticas contendo ditos macrolìdeos.
CA2044507A1 (en) Gemfibrozil formulations

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties